Abnormality of alphafetoprotein 2016 2017 2018 2019 2020 2021 Billable/Specific Code R77.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM R77.2 became effective on October 1, 2020.
Other abnormal tumor markers. R97.8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM R97.8 became effective on October 1, 2018.
Elevated ca 27-30 ICD-10-CM R97.8 is grouped within Diagnostic Related Group (s) (MS-DRG v38.0): 947 Signs and symptoms with mcc 948 Signs and symptoms without mcc
The 2022 edition of ICD-10-CM O28.1 became effective on October 1, 2021. This is the American ICD-10-CM version of O28.1 - other international versions of ICD-10 O28.1 may differ. O28.1 is applicable to maternity patients aged 12 - 55 years inclusive.
ICD-10 code R79. 89 for Other specified abnormal findings of blood chemistry is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
There are four different ICD-10 diagnosis codes for the four conditions listed above. For example, a liver lesion is coded as K76. 9; a liver mass is coded as R16. 0, a liver tumor is coded as D49.
ICD-10-CM Code for Elevation of levels of liver transaminase levels R74. 01.
R97. 8 - Other abnormal tumor markers. ICD-10-CM.
The 2022 edition of ICD-10-CM K76. 89 became effective on October 1, 2021. This is the American ICD-10-CM version of K76.
Hepatic tumors are a diverse group of masses that include malignant and benign subtypes. Their presentation can vary from localizing signs/symptoms, such as jaundice and right upper quadrant pain, to vague signs/symptoms, such as fatigue, weight loss, and anorexia.
Code R74. 0 Nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [LDH], has been expanded to separately report elevation of levels of liver transminase (R74.
ICD-10 code R94. 5 for Abnormal results of liver function studies is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
821. Revised descriptor for ICD-10-CM diagnosis code Z77. 29.
LOINC MapOrder CodeOrder Code NameResult Code002253AFP, Serum, Tumor Marker002266
CEA stands for carcinoembryonic antigen. It is a protein found in the tissues of a developing baby. CEA levels normally become very low or disappear after birth. Healthy adults should have very little or no CEA in their body. This test measures the amount of CEA in the blood, and sometimes in other body fluids.
NCD - Tumor Antigen by Immunoassay - CA 19-9 (190.30) The .
Elevated alpha-fetoprotein refers to a state where alpha-fetoprotein levels are outside of the reference range.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code R77.2. Click on any term below to browse the alphabetical index.
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code R77.2 and a single ICD9 code, 790.99 is an approximate match for comparison and conversion purposes.